The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Researchers have been studying metastasis for more than 100 years, and only recently have we gained insight into the mechanisms by which metastatic cells arise from primary tumours and the reasons that certain tumour types tend to metastasize to specific organs. Stephen Paget's 1889 proposal that metastasis depends on cross-talk between selected cancer cells (the 'seeds') and specific organ microenvironments (the 'soil') still holds forth today. It is now known that the potential of a tumour cell to metastasize depends on its interactions with the homeostatic factors that promote tumour-cell growth, survival, angiogenesis, invasion and metastasis. How has this field developed over the past century, and what major breakthroughs are most likely to lead to effective therapeutic approaches?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is particularly important as there is growing evidence that cancer cells communicate with their microenvironment[29], specifically with organ-specific cells[30], resulting in organ-selectivity in metastasis[31].”
From Microfluidics: A New Tool for Modeling Cancer–Immune Interactions (2016) · cites this paper as [31]
Citations
Cites
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Mutations of bacteria from virus sensitivity to virus resistance
Luria, S. E., & Delbrück, M. (1943) · Genetics · doi:10.1093/genetics/28.6.491 · Cited by 3,894
The pathogenesis of cancer metastasis
Poste, G., & Fidler, I. J. (1980) · Nature · doi:10.1038/283139a0 · Cited by 1,739
Self-citationMetastasis Results from Preexisting Variant Cells Within a Malignant Tumor
Fidler, I. J., & Kripke, M. L. (1977) · Science · doi:10.1126/science.887927 · Cited by 1,425
Self-citationTumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.
Liotta, L. A. (1986) · PubMed · Cited by 1,400
Selection of Successive Tumour Lines for Metastasis
FIDLER, I. J. (1973) · Nature New Biology · doi:10.1038/newbio242148a0 · Cited by 1,361
Self-citationFidler, I. J. (1990) · PubMed · Cited by 1,278
Self-citationOrgan targeting In vivo using phage display peptide libraries
Pasqualini, R., & Ruoslahti, E. (1996) · Nature · doi:10.1038/380364a0 · Cited by 1,221
(1970) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/45.4.773 · Cited by 1,025
Self-citation
Research works printed but not linked: 6
- Ewing, J. Neoplastic Diseases edn 6 (W. B. Saunders, Philadelphia, 1928).
- Fisher, B. & Fisher, E. R. The organ distribution of disseminated 51Cr-labeled tumour cells. Cancer Res. 27, 412–419 (1967).
- Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumour emboli labeled with 125I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst. 45, 773–782 (1970).
- Weiss, L. Metastatic inefficiency: causes and consequences. Cancer Metastasis Rev. 3, 1–24 (1986).
- Heppner, G. Tumour heterogeneity. Cancer Res. 44, 2259–2265 (1984).
- Foulds, L. The experimental study of tumour progression. Cancer Res. 14, 327–339 (1954).
Cited by
Items 201–300 of 1,014
Molecular interactions in cancer cell metastasis
Brooks, S. A., Lomax-Browne, H. J., Carter, T. M., Kinch, C. E., & Hall, D. M. S. (2010) · Acta Histochemica · doi:10.1016/j.acthis.2008.11.022 · Cited by 312
Metastasis: cancer cell’s escape from oxidative stress
Pani, G., Galeotti, T., & Chiarugi, P. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9225-4 · Cited by 313
“Moreover, prompted by these indications, detailed biochemical studies have provided new information on the complex interaction between metastatic cells and the components (stromal vascular and inflammatory cells) of their ectopic microenvironment, leading to a new molecular definition of the old Paget’s seed and soil…”
BackgroundThe Role of the Microenvironment in Mammary Gland Development and Cancer
Polyak, K., & Kalluri, R. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003244 · Cited by 311
Mechanisms of tumor cell extravasation in an in vitro microvascular network platform
Chen, M. B., Whisler, J. A., Jeon, J. S., & Kamm, R. D. (2013) · Integrative Biology · doi:10.1039/c3ib40149a · Cited by 308
Gao, D., Joshi, N., Choi, H., Ryu, S., Hahn, M., Catena, R., Sadik, H., Argani, P., Wagner, P., Vahdat, L. T., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2905 · Cited by 307
“org Cancer Res; 72(6) March 15, 2012 1391”
InfluentialMicroenvironmental Regulation of Epithelial–Mesenchymal Transitions in Cancer
Gao, D., Vahdat, L. T., Wong, S., Chang, J. C., & Mittal, V. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1223 · Cited by 305
“As early as 1889, Steven Paget proposed his "seed and soil" hypothesis, establishing the concept that a fertile "soil" (the microenvironment) is critical for the disseminated tumor cell (the "seed") to grow (65, 66).”
Bone Marrow Microenvironment in Multiple Myeloma Progression
Manier, S., Sacco, A., Leleu, X., Ghobrial, I. M., & Roccaro, A. M. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/157496 · Cited by 301
“However the new host microenvironment is not well adapted to the cancer cells that metastasized into it, leading to the new concept of premetastatic niche [8].”
BackgroundInfluentialLi, X., Shan, J., Zhang, W., Su, S., Yuwen, L., & Wang, L. (2017) · Small · doi:10.1002/smll.201602660 · Cited by 301
Dzutsev, A., Badger, J. H., Perez-Chanona, E., Roy, S., Salcedo, R., Smith, C. K., & Trinchieri, G. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052133 · Cited by 302
“However, it is becoming evident that transformed cells cannot effectively grow without a suitable microenvironment (56).”
BackgroundPeng, Y.-F., Shi, Y.-H., Ding, Z.-B., Ke, A.-W., Gu, C.-Y., Hui, B., Zhou, J., Qiu, S.-J., Dai, Z., & Fan, J. (2013) · Autophagy · doi:10.4161/auto.26398 · Cited by 295
Aghdassi, A., Sendler, M., Guenther, A., Mayerle, J., Behn, C.-O., Heidecke, C.-D., Friess, H., Büchler, M., Evert, M., Lerch, M. M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300060 · Cited by 289
Bacac, M., & Stamenkovic, I. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151523 · Cited by 286
Mathematical modelling of cancer invasion of tissue: dynamic heterogeneity
Chaplain, M. A. J., T. S. C., & Lolas, G. (2006) · Networks & Heterogeneous Media · doi:10.3934/nhm.2006.1.399 · Cited by 283
“Identifying the mechanisms that keep metastases in their dormant, occult state is one of the most challenging and important avenues of cancer research ([19], [40]).”
BackgroundGenomic Instability of iPSCs: Challenges Towards Their Clinical Applications
Yoshihara, M., Hayashizaki, Y., & Murakawa, Y. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9680-6 · Cited by 283
“[47] for review) Tumorigenic potential might also differ depending on the environment [48] surrounding the transplanted cells.”
BackgroundAn, T., Qin, S., Xu, Y., Tang, Y., Huang, Y., Situ, B., Inal, J. M., & Zheng, L. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27522 · Cited by 282
Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
Wu, S., Liu, S., Liu, Z., Huang, J., Pu, X., Li, J., Yang, D., Deng, H., Yang, N., & Xu, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123976 · Cited by 282
“Metastasis is a multi-step process with the presence of circulating tumor cells (CTCs) in the blood stream and disseminated tumor cells (DTCs) that home to the bone marrow [1].”
BackgroundPhosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis
Jin, L., Chun, J., Pan, C., Alesi, G. N., Li, D., Magliocca, K. R., Kang, Y., Chen, Z. G., Shin, D. M., Khuri, F. R., et al. (2017) · Oncogene · doi:10.1038/onc.2017.6 · Cited by 281
Xu, L., Begum, S., Hearn, J. D., & Hynes, R. O. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602681103 · Cited by 279
Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis
Saini, S., Majid, S., Yamamura, S., Tabatabai, L., Suh, S. O., Shahryari, V., Chen, Y., Deng, G., Tanaka, Y., & Dahiya, R. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2619 · Cited by 275
“Metastasis involves multiple sequential steps including the escape of neoplastic cells from a primary tumor (local invasion), intravasation into the systemic circulation, survival during transit through the vasculature, extravasation into distant tissues, and finally, proliferation at a new site (2).”
BackgroundQu, G., Xia, T., Zhou, W., Zhang, X., Zhang, H., Hu, L., Shi, J., Yu, X.-F., & Jiang, G. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00445 · Cited by 275
Emerging role of tumor cell plasticity in modifying therapeutic response
Qin, S., Jiang, J., Lu, Y., Nice, E. C., Huang, C., Zhang, J., & He, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00313-5 · Cited by 268
MicroRNA control of epithelial–mesenchymal transition and metastasis
Zhang, J., & Ma, L. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9368-6 · Cited by 273
“Around 90% of cancer-related mortality is caused by metastasis, a multi-step process in which tumor cells disseminate from the primary site, enter lymphatic or blood circulation, arrest at distant anatomic sites, exit the vasculature, and colonize distant organs through metastatic outgrowth [1].”
BackgroundLymphatic or Hematogenous Dissemination: How Does a Metastatic Tumor Cell Decide?
Wong, S. Y., & Hynes, R. O. (2006) · Cell Cycle · doi:10.4161/cc.5.8.2646 · Cited by 266
“Or, the tumor is completely nonmetastatic until mobilized to metastasize via both lymphatic and hematogenous routes at the same time (2).”
BackgroundLianidou, E. S., & Markou, A. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.165068 · Cited by 265
RAC1: An Emerging Therapeutic Option for Targeting Cancer Angiogenesis and Metastasis
Bid, H. K., Roberts, R. D., Manchanda, P. K., & Houghton, P. J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0164 · Cited by 265
“underlying cellular and molecular events that control the metastatic cascade from onset to colonization (24).”
BackgroundDas, V., Bhattacharya, S., Chikkaputtaiah, C., Hazra, S., & Pal, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28160 · Cited by 263
“Cancer metastasis is a complex process where the variety of alternations occur termed as the invasion‐metastasis cascade (Croker & Allan, 2008; Fidler, 2003) followed by a variation of the gene expression signatures and cellular morphology (Fidler, 2003).”
BackgroundExpression, regulation, and function of exosome‐derived miRNAs in cancer progression and therapy
Li, B., Cao, Y., Sun, M., & Feng, H. (2021) · The FASEB Journal · doi:10.1096/fj.202100294rr · Cited by 262
Stepping out of the flow: capillary extravasation in cancer metastasis
Miles, F. L., Pruitt, F. L., van Golen, K. L., & Cooper, C. R. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9098-2 · Cited by 262
Engineering nanoparticles to locally activate T cells in the tumor microenvironment
Wang, D., Wang, T., Yu, H., Feng, B., Zhou, L., Zhou, F., Hou, B., Zhang, H., Luo, M., & Li, Y. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau6584 · Cited by 261
Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone
Pratap, J., Lian, J. B., Javed, A., Barnes, G. L., van Wijnen, A. J., Stein, J. L., & Stein, G. S. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9032-0 · Cited by 262
“Matrix metalloproteinases [84, 110]”
Roles of small RNAs in tumor formation
Di Leva, G., & Croce, C. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.04.001 · Cited by 262
Schultheis, B., Strumberg, D., Santel, A., Vank, C., Gebhardt, F., Keil, O., Lange, C., Giese, K., Kaufmann, J., Khan, M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0376 · Cited by 260
Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis
Marchesi, F., Piemonti, L., Mantovani, A., & Allavena, P. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.001 · Cited by 260
“whereby cancer cells leave the primary tumor site and disseminate to distant organs [1].”
BackgroundMRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent
Zhou, Z., Qutaish, M., Han, Z., Schur, R. M., Liu, Y., Wilson, D. L., & Lu, Z.-R. (2015) · Nature Communications · doi:10.1038/ncomms8984 · Cited by 260
Peña-Romero, A. C., & Orenes-Piñero, E. (2022) · Cancers · doi:10.3390/cancers14071681 · Cited by 257
Molecular imaging of the tumor microenvironment
Zhou, Z., & Lu, Z.-R. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.012 · Cited by 253
Organotropism of Breast Cancer Metastasis
Lu, X., & Kang, Y. (2007) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-007-9047-3 · Cited by 259
“He speculated that malignant tumor cells are shed from the primary tumor and disseminated throughout the body, but metastases form only when the seed (disseminated tumor cells) and soil (secondary organ) are compatible [13, 14].”
Circulating tumour cells: their utility in cancer management and predicting outcomes
Krebs, M. G., Hou, J.-M., Ward, T. H., Blackhall, F. H., & Dive, C. (2010) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834010378414 · Cited by 259
“The entire process of metastasis appears to be inefficient in that only the ‘decathlon champions’ of CTCs (as coined by Isaiah Fidler [Fidler, 2003]) are successful in establishing distant metastatic disease.”
BackgroundBrain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
Sullivan, J. P., Nahed, B. V., Madden, M. W., Oliveira, S. M., Springer, S., Bhere, D., Chi, A. S., Wakimoto, H., Rothenberg, S. M., Sequist, L. V., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0471 · Cited by 255
“As exemplified by the “seed” versus “soil” debate (4), it is unclear whether GBM cells are incapable of invading into the vasculature or whether invasive GBM cells circulate in the blood but are unable to proliferate in tissues outside of the brain.”
BackgroundEpithelial-mesenchymal transition, cancer stem cells and treatment resistance
Dave, B., Mittal, V., Tan, N. M., & Chang, J. C. (2012) · Breast Cancer Research · doi:10.1186/bcr2938 · Cited by 257
“Following dissemination, establishment of metastatic lesions depends on the organ-colonizing proper ties of disseminated tumor cells as well as on permissive conditions also referred to as the metastatic niche that may be present in the restrictive micro environment of target organs [28,29].”
BackgroundDavoren, P. A., McNeill, R. E., Lowery, A. J., Kerin, M. J., & Miller, N. (2008) · BMC Molecular Biology · doi:10.1186/1471-2199-9-76 · Cited by 257
Li, Z., Jiang, P., Li, J., Peng, M., Zhao, X., Zhang, X., Chen, K., Zhang, Y., Liu, H., Gan, L., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0237-9 · Cited by 257
Frontiers in cancer nanomedicine: directing mass transport through biological barriers
Ferrari, M. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.12.007 · Cited by 255
“Cancer is s a disease of the cell, which is inextricably linked to its surrounding biological milieu through a complexity of interactions with its microenvironment and distant sites within the host organism [1,2].”
BackgroundCurrent and emerging concepts in tumour metastasis
Coghlin, C., & Murray, G. I. (2010) · The Journal of Pathology · doi:10.1002/path.2727 · Cited by 257
Xu, L., Shen, S. S., Hoshida, Y., Subramanian, A., Ross, K., Brunet, J.-P., Wagner, S. N., Ramaswamy, S., Mesirov, J. P., & Hynes, R. O. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0344 · Cited by 254
“Clinicians often find a large number of circulating tumor cells in cancer patients, but not many detectable metastases (4, 5).”
BackgroundLi, L., & Li, W. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.004 · Cited by 254
“The microenvironment is a strong determinant of whether or not cancer cells acquire the potential to undergo EMT and metastasize (Fidler, 2003; Joyce & Pollard, 2009).”
BackgroundNon-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion
Song, Y.-X., Sun, J.-X., Zhao, J.-H., Yang, Y.-C., Shi, J.-X., Wu, Z.-H., Chen, X.-W., Gao, P., Miao, Z.-F., & Wang, Z.-N. (2017) · Nature Communications · doi:10.1038/s41467-017-00304-1 · Cited by 253
Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer
Deep, G., & Agarwal, R. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9237-0 · Cited by 253
“This theory, which placed main emphasis on the compatibility between metastatic cancer cells and their microenvironment, was contested by James Ewing, who alternatively proposed that metastatic propensity of cancer cells is mostly dictated by circulatory patterns, and that metastasizing cancer cells would settle in or…”
BackgroundMcKay, R. R., Kroeger, N., Xie, W., Lee, J.-L., Knox, J. J., Bjarnason, G. A., MacKenzie, M. J., Wood, L., Srinivas, S., Vaishampayan, U. N., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.08.012 · Cited by 253
“Given the significant intratumor heterogeneity in patients with metastatic RCC, the unique organ microenvironment of the liver may be selective for a more aggressive clinical phenotype [17,18].”
Hu, Z., Zhou, S., Li, J., Zhou, Z., Wang, P., Xin, H., Mao, L., Luo, C., Yu, S., Huang, X., et al. (2020) · Hepatology · doi:10.1002/hep.31068 · Cited by 252
“We considered oncogenes/tumor suppressor genes and cytokines/chemokines that met all three of the following criteria to be target genes of miR-326 and miR-532-5p: (1) down-regulated in HCCLM3 cells transfected with miR-326 or miR-532-5p; (2) up-regulated in PLC/ PRF/5 cells transfected with anti-miR-326 or antimiR-532…”
BackgroundS1PR1-STAT3 Signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic Sites
Deng, J., Liu, Y., Lee, H., Herrmann, A., Zhang, W., Zhang, C., Shen, S., Priceman, S. J., Kujawski, M., Pal, S. K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.039 · Cited by 252
“Initiation of metastasis involves intravasation of tumor stromal cells, including myeloid cells, from primary tumor sites (Fidler, 2003).”
SPARC and tumor growth: Where the seed meets the soil?
Framson, P. E., & Sage, E. H. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20091 · Cited by 249
Zijlstra, A., Lewis, J., DeGryse, B., Stuhlmann, H., & Quigley, J. P. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.031 · Cited by 248
Azab, B., Shah, N., Radbel, J., Tan, P., Bhatt, V., Vonfrolio, S., Habeshy, A., Picon, A., & Bloom, S. (2013) · Medical Oncology · doi:10.1007/s12032-012-0432-4 · Cited by 249
“This aggregation of platelets and tumor cells may promote tumor cell survival [37].”
BackgroundInsulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo
Björndahl, M., Cao, R., Nissen, L. J., Clasper, S., Johnson, L. A., Xue, Y., Zhou, Z., Jackson, D., Jon Hansen, A., & Cao, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507865102 · Cited by 249
Exosomes: Key mediators of metastasis and pre-metastatic niche formation
Lobb, R. J., Lima, L. G., & Möller, A. (2017) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.01.004 · Cited by 249
Pulmonary Vascular Destabilization in the Premetastatic Phase Facilitates Lung Metastasis
Huang, Y., Song, N., Ding, Y., Yuan, S., Li, X., Cai, H., Shi, H., & Luo, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4382 · Cited by 247
“The metastasis depends on both the intrinsic properties of the tumor cells and their interactions with the host microenvironment (14, 15).”
BackgroundID genes mediate tumor reinitiation during breast cancer lung metastasis
Gupta, G. P., Perk, J., Acharyya, S., de Candia, P., Mittal, V., Todorova-Manova, K., Gerald, W. L., Brogi, E., Benezra, R., & Massagué, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709185104 · Cited by 247
Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model
Marques, I. J., Weiss, F. U., Vlecken, D. H., Nitsche, C., Bakkers, J., Lagendijk, A. K., Partecke, L. I., Heidecke, C.-D., Lerch, M. M., & Bagowski, C. P. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-128 · Cited by 247
Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis
Shu, L., Cheung, K.-L., Khor, T. O., Chen, C., & Kong, A.-N. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9239-y · Cited by 245
“The “seed and soil” concept that was first proposed by Stephen Paget in 1889 still holds true today since metastasis depends on cross talk between the selected cancer cells (seeds) and the microenvironment (soil) [108].”
BackgroundEmerging Role of Nanomaterials in Circulating Tumor Cell Isolation and Analysis
Yoon, H. J., Kozminsky, M., & Nagrath, S. (2014) · ACS Nano · doi:10.1021/nn5004277 · Cited by 245
“proliferate to form secondary tumor colonies (Figure 1).(3,4) To migrate through the”
BackgroundDistinct mechanisms of tumor invasion and metastasis
Yilmaz, M., Christofori, G., & Lehembre, F. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.10.004 · Cited by 245
Wen, C.-Y., Wu, L.-L., Zhang, Z.-L., Liu, Y.-L., Wei, S.-Z., Hu, J., Tang, M., Sun, E.-Z., Gong, Y.-P., Yu, J., et al. (2014) · ACS Nano · doi:10.1021/nn405744f · Cited by 242
Cancer Stem Cells, Hypoxia and Metastasis
Hill, R. P., Marie-Egyptienne, D. T., & Hedley, D. W. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.12.002 · Cited by 238
Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy
Mishra, P., Banerjee, D., & Ben-Baruch, A. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310182 · Cited by 239
Matrix metalloproteinases at cancer tumor–host interface
NOEL, A., JOST, M., & MAQUOI, E. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.05.011 · Cited by 239
“microenvironment during cancer progression has already been recognized more than 100 years ago in the “seed and soil” hypothesis proposed by Paget in 1889 [2].”
BackgroundOjalvo, L. S., Whittaker, C. A., Condeelis, J. S., & Pollard, J. W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902360 · Cited by 238
“A second mechanism by which TAMs facilitate tumor metastasis is through directly enhancing an early stage of the metastatic cascade (16): carcinoma cell invasion.”
BackgroundDeryugina, E. I., & Quigley, J. P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.09.017 · Cited by 238
“The findings generated in a number of in vitro, ex vivo and in vivo model systems have clearly implicated MMP-14 in matrix modifications that allow for coordinated migration and invasion of tumor and endothelial cells [71,100,101,103,119].”
BackgroundHost Factors and Cancer Progression: Biobehavioral Signaling Pathways and Interventions
Lutgendorf, S. K., Sood, A. K., & Antoni, M. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.9357 · Cited by 237
“and evasion of immune system surveillance.(20) Increasing evidence shows that stress response pathways can affect many parts of this cascade (Fig 1).”
BackgroundIn vitro model of tumor cell extravasation
Jeon, J. S., Zervantonakis, I. K., Chung, S., Kamm, R. D., & Charest, J. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056910 · Cited by 233
Aptamer-Enabled Efficient Isolation of Cancer Cells from Whole Blood Using a Microfluidic Device
Sheng, W., Chen, T., Kamath, R., Xiong, X., Tan, W., & Fan, Z. H. (2012) · Analytical Chemistry · doi:10.1021/ac3005633 · Cited by 236
Targeting Breast Cancer Metastasis
Jin, X., & Mu, P. (2015) · Breast Cancer: Basic and Clinical Research · doi:10.4137/bcbcr.s25460 · Cited by 233
Suppression of Tumor Development and Metastasis Formation in Mice Lacking the S100A4(mts1) Gene
Grum-Schwensen, B., Klingelhofer, J., Berg, C. H., El-Naaman, C., Grigorian, M., Lukanidin, E., & Ambartsumian, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4510 · Cited by 235
“Metastases, growth of the tumor cells at secondary sites, are determined by a complex cascade of events that involves both cancer cells and multiple factors produced by the host organism (1).”
BackgroundLisanti, M. P., Martinez-Outschoorn, U. E., Lin, Z., Pavlides, S., Whitaker-Menezes, D., Pestell, R. G., Howell, A., & Sotgia, F. (2011) · Cell Cycle · doi:10.4161/cc.10.15.16870 · Cited by 234
The Prognostic Significance of Fibrosarcomatous Transformation in Dermatofibrosarcoma Protuberans
Abbott, J. J., Oliveira, A. M., & Nascimento, A. G. (2006) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200604000-00002 · Cited by 237
“Metastatic potential for most neoplasms, in contrast, seems to be primarily dictated by the biologic events within tumor cells as well as by a series of microenvironmental factors, such as stromal-tumor interactions.(8,16,29) However, it is important to emphasize that the events that influence local recurrence and tho…”
BackgroundBelletti, B., Vaidya, J. S., D'Andrea, S., Entschladen, F., Roncadin, M., Lovat, F., Berton, S., Perin, T., Candiani, E., Reccanello, S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4453 · Cited by 234
Heymann, M.-F., Lézot, F., & Heymann, D. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.011 · Cited by 233
Sun, X., He, X., Zhang, Y., Hosaka, K., Andersson, P., Wu, J., Wu, J., Jing, X., Du, Q., Hui, X., et al. (2022) · Gut · doi:10.1136/gutjnl-2020-322744 · Cited by 233
Luo, W. (2023) · Theranostics · doi:10.7150/thno.82690 · Cited by 233
Suh, Y., Yoon, C.-H., Kim, R.-K., Lim, E.-J., Oh, Y. S., Hwang, S.-G., An, S., Yoon, G., Gye, M. C., Yi, J.-M., et al. (2013) · Oncogene · doi:10.1038/onc.2012.505 · Cited by 230
RetractedMujoomdar, A., Austin, J. H. M., Malhotra, R., Powell, C. A., Pearson, G. D. N., Shiau, M. C., & Raftopoulos, H. (2007) · Radiology · doi:10.1148/radiol.2423051707 · Cited by 228
Lin, Q., Balasubramanian, K., Fan, D., Kim, S.-J., Guo, L., Wang, H., Bar-Eli, M., Aldape, K. D., & Fidler, I. J. (2010) · Neoplasia · doi:10.1593/neo.10602 · Cited by 228
“The outcome of brain metastasis in patients depends on multiple interactions between tumor cells and the tumor microenvironment, which metastatic cells exploit to their advantage [8,9].”
BackgroundSelf-citationSpahn, M., Kneitz, S., Scholz, C., Stenger, N., Rüdiger, T., Ströbel, P., Riedmiller, H., & Kneitz, B. (2010) · International Journal of Cancer · doi:10.1002/ijc.24715 · Cited by 228
“This result is consistent with a clonal development of metastasis from the primary tumor.(27) It shows that miR-expression is not substantially altered in metastasising PCa.”
ResultMicrofluidics: A New Tool for Modeling Cancer–Immune Interactions
Boussommier-Calleja, A., Li, R., Chen, M. B., Wong, S. C., & Kamm, R. D. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2015.12.003 · Cited by 224
“This is particularly important as there is growing evidence that cancer cells communicate with their microenvironment[29], specifically with organ-specific cells[30], resulting in organ-selectivity in metastasis[31].”
BackgroundMicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1
Yang, S., Li, Y., Gao, J., Zhang, T., Li, S., Luo, A., Chen, H., Ding, F., Wang, X., & Liu, Z. (2013) · Oncogene · doi:10.1038/onc.2012.432 · Cited by 228
Cell Clustering Promotes a Metabolic Switch that Supports Metastatic Colonization
Labuschagne, C. F., Cheung, E. C., Blagih, J., Domart, M.-C., & Vousden, K. H. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.014 · Cited by 225
“720 Cell Metabolism 30, 720–734, October 1, 2019 ª 2019 The Autho This is an open access article under the CC BY license (http://creative ated with movement out of the primary tumor, entry into the circulation, and re-establishment within a distant organ (Fidler, 2003; Hunter et al., 2008).”
BackgroundExosomes: Small vesicles with big roles in cancer, vaccine development, and therapeutics
Thakur, A., Parra, D. C., Motallebnejad, P., Brocchi, M., & Chen, H. J. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.08.029 · Cited by 224
Exosomes: The Messengers of Health and Disease
Isola, A. L., & Chen, S. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160825160421 · Cited by 223
“Cancer patients have been shown to harbor primary tumors that preferentially hone to particular organs, for example, melanoma selectively metastasizes to the lung and brain [103].”
InfluentialKlarmann, G. J., Hurt, E. M., Mathews, L. A., Zhang, X., Duhagon, M. A., Mistree, T., Thomas, S. B., & Farrar, W. L. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9242-2 · Cited by 221
“Finally, the microenvironment (or niche) must be permissible so the cell propagates and establishes a metastatic secondary lesion [1-3].”
BackgroundThe Spemann organizer gene, Goosecoid , promotes tumor metastasis
Hartwell, K. A., Muir, B., Reinhardt, F., Carpenter, A. E., Sgroi, D. C., & Weinberg, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608636103 · Cited by 220
Linking the future of anticancer metal-complexes to the therapy of tumour metastases
Bergamo, A., & Sava, G. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00134j · Cited by 219
Weng, C.-J., & Yen, G.-C. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9347-y · Cited by 219
“In 2003, Fidler [59] proposed the " seed and soil hypothesis " to explain the phenomenon of a certain tumor cell (the " seed " ) becoming embedded in a specific target organ (the " soil " ).”
Motohara, T., Masuda, K., Morotti, M., Zheng, Y., El-Sahhar, S., Chong, K. Y., Wietek, N., Alsaadi, A., Carrami, E. M., Hu, Z., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0637-x · Cited by 218
Zhao, X., Dou, W., He, L., Liang, S., Tie, J., Liu, C., Li, T., Lu, Y., Mo, P., Shi, Y., et al. (2013) · Oncogene · doi:10.1038/onc.2012.156 · Cited by 218
Luo, M., Brooks, M., & Wicha, M. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666141211120604 · Cited by 215
Extracellular Vesicles – Biomarkers and Effectors of the Cellular Interactome in Cancer
Rak, J. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00021 · Cited by 215
“Different populations of cancer cells colonize specific organ sites in a process now known to be influenced not only by the cancer cell genome, but also by the host genetic background and tissue microenvironment (Paget, 1889; Fidler, 2003; Hunter, 2006; Chiang and Massague, 2008).”
BackgroundPng, K. J., Yoshida, M., Zhang, X. H.-F., Shu, W., Lee, H., Rimner, A., Chan, T. A., Comen, E., Andrade, V. P., Kim, S. W., et al. (2011) · Genes & Development · doi:10.1101/gad.1974211 · Cited by 215
“The mechanistic dissection of the metastatic cascade has benefitted much from both pioneering mouse xenograft models of human cancer cells (Fidler 2003) and transcriptomic profiling techniques (van de Vijver et al. 2002).”
MethodJacques, T. S., Swales, A., Brzozowski, M. J., Henriquez, N. V., Linehan, J. M., Mirzadeh, Z., O' Malley, C., Naumann, H., Alvarez‐Buylla, A., & Brandner, S. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.327 · Cited by 214
“SVZ versus non-neurogenic regions) is for the formation of tumours (seed and soil hypothesis; for review, see Fidler (2003)).”
BackgroundCollective behavior in cancer cell populations
Deisboeck, T. S., & Couzin, I. D. (2009) · BioEssays · doi:10.1002/bies.200800084 · Cited by 213
“190 combination of fast on-site growth and a (currently) nearly unstoppable population of rogue, mobile cancerous cells that invade the adjacent tissue and, depending on the cancer type, can eventually metastasize to other organs and set up secondary tumors.((11)) In some microscopy images (such as the one in Fig.”
BackgroundSmall-molecule delivery by nanoparticles for anticancer therapy
Chen, Z. (. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.08.001 · Cited by 212
“Based on the “seed and soil” theory, there are common metastatic sites for certain types of cancers [90,91].”
Background
Metadata
- Authors
- Fidler, I. J.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Fidler, Isaiah J.
- Venue
- Nature Reviews Cancer
- Published
- 2003-06
- Volume
- 3
- Issue
- 6
- Pages
- 453-458
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1520425169
- Cited by
- 4,686
- References
- 40
- Citations by year
- 2026: 101 · 2025: 140 · 2024: 168 · 2023: 203 · 2022: 212 · 2021: 271 · 2020: 243 · 2019: 274 · 2018: 251 · 2017: 292 · 2016: 298 · 2015: 263 · 2014: 286 · 2013: 288 · 2012: 248
- FWCI
- 8.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Metastasis and carcinoma case studies
- Keywords
- metastasis, seed and soil hypothesis, tumor microenvironment, organ-specific metastasis, tumor invasion, angiogenesis, tumor cell survival, metastasis treatment
- MeSH terms
- Humans, Medical Oncology, Neoplasm Metastasis, History, 19th Century, History, 20th Century, History, 21st Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.